Yf-Vax Global Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

YF-Vax is a live-attenuated vaccine designed to provide long-term protection against yellow fever, a potentially serious viral disease transmitted by infected mosquitoes. It is commonly recommended for travelers and residents in endemic regions.

The main forms of YF-Vax are live attenuated vaccines and fractional dose vaccines. Live attenuated vaccines contain live, but weakened, forms of the virus that cause the disease. Yellow fever can be transmitted through sylvatic, intermediate, and urban cycles. YF-Vax is distributed through hospitals, retail pharmacies, and government health programs, and is used by adults, geriatric populations, and pediatric patients.

Tariffs have affected the yf-vax market by increasing costs of vaccine manufacturing materials and cold chain distribution systems. These impacts are most visible in government health programs across africa, latin america, and parts of asia pacific. Higher import duties have influenced procurement budgets for large scale immunization campaigns. Logistics timelines have also been impacted by cross border regulatory requirements. However, tariffs are encouraging localized vaccine production and regional supply self sufficiency.

The yf-vax market research report is one of a series of new reports from The Business Research Company that provides yf-vax market statistics, including yf-vax industry global market size, regional shares, competitors with a yf-vax market share, detailed yf-vax market segments, market trends and opportunities, and any further data you may need to thrive in the yf-vax industry. This yf-vax market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The yf-vax market size has grown strongly in recent years. It will grow from $6.78 million in 2025 to $7.32 million in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to yellow fever endemic regions, international travel requirements, proven long term immunity, government vaccination mandates, public health initiatives.

The yf-vax market size is expected to see strong growth in the next few years. It will grow to $9.81 million in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing global travel, climate driven mosquito spread, expanded immunization coverage, rising outbreak preparedness funding, public health surveillance growth. Major trends in the forecast period include rising demand for travel vaccination, government led immunization programs, continued use of live attenuated vaccines, focus on endemic disease prevention, stockpiling for outbreak preparedness.

The growing awareness of vector-borne diseases is expected to drive the growth of the YF-Vax market in the coming years. Vector-borne diseases are infectious illnesses transmitted to humans and animals through the bites of infected arthropods, such as mosquitoes, ticks, and fleas, carrying viruses, bacteria, or parasites, which can cause diseases like malaria, dengue, and Lyme disease. The increasing prevalence of vector-borne diseases is attributed to climate change, urbanization, global travel, and expanding mosquito populations, resulting in more reported outbreaks. YF-Vax provides effective protection against yellow fever, a vector-borne disease, by stimulating the immune system to produce antibodies and ensuring long-lasting immunity against the virus transmitted by infected mosquitoes. For example, in March 2024, the World Organization for Animal Health reported 2,422 vector-borne disease outbreaks across 28 countries from 2023 to March 2024, with Europe alone accounting for 697 outbreaks. Therefore, increasing awareness of vector-borne diseases is supporting growth in the YF-Vax market.

The rising demand for international travel is also expected to propel the YF-Vax market forward. International travel involves crossing national borders for purposes such as tourism, business, education, or visiting family. The increase in global disposable incomes has enabled more people to travel abroad for leisure, boosting the need for preventive vaccination among travelers visiting yellow fever-endemic regions. Travel-related vaccine requirements further drive uptake, ensuring protection against outbreaks and supporting public health efforts worldwide. For instance, in June 2025, FREETOUR.com reported that UK residents made over 90 million outbound trips in 2024 and are projected to make over 92 million outbound trips while receiving 43.4 million international visitors in 2025. Consequently, the rising demand for international travel is contributing to the growth of the YF-Vax market.

Rising healthcare spending is also expected to support the growth of the YF-Vax market. Healthcare expenditure, driven by aging populations, technological advancements, the increasing prevalence of chronic diseases, and greater demand for healthcare services, underpins vaccination efforts. YF-Vax reduces healthcare costs by preventing severe infections, hospitalizations, and outbreak management expenses. For example, in May 2024, the UK's Office for National Statistics reported that healthcare spending increased by 5.6% between 2022 and 2023, compared with 0.9% growth in 2022, reaching approximately $317.63 billion (£292 billion) in 2023. Therefore, rising healthcare expenditure is driving growth in the YF-Vax market.

Major companies operating in the yf-vax market are Sanofi S.A.

North America was the largest region in the yf-vax market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yf-vax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the yf-vax market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

The yf-vax market consists of sales of vaccine syringes, pre-filled injection devices, and immunization kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Yf-Vax Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses yf-vax market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for yf-vax ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The yf-vax market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Vaccine Type: Live Attenuated Vaccines; Fractional Dose Vaccine
• 2) By Transmission Type: Sylvatic Yellow Fever; Intermediate Yellow Fever; Urban Yellow Fever
• 3) By Distribution Channel: Hospitals; Retail Pharmacies; Government Health Programs
• 4) By End User: Adult; Geriatric; Pediatric
• Companies Mentioned: Sanofi S.A.
• Countries: Australia; India; China; South Korea; Japan; UK; France; Germany; USA; Canada.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.